BDNF in quinolinic acid lesioned rats after bone marrow cells transplant

Neuroscience Letters

Volumn 559, Issue , 2014, Pages 147-151

  Serrano Sanchez T ^a   Alberti Amador, E ^a   Lorigados Pedre, L ^a   Blanco Lezcano, L ^a   Diaz Armesto, I ^a   Bergado, J A ^a  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

Author keywords

Bone marrow stem cells (BMC); Brain derived neurotrophic factor (BDNF); Huntington's disease (HD); Quinolinic acid; Transplant

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT;

BONE MARROW STEM CELLS (BMC); BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF); HUNTINGTON'S DISEASE (HD); QUINOLINIC ACID; TRANSPLANT;

ANIMALS; BONE MARROW TRANSPLANTATION; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; CORPUS STRIATUM; MALE; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84890838346     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.11.060     Document Type: Article

References (34)

1. Huntington G. On chorea. Med. Surg. Rep. 1872, 26:317-321.
2. Imarisio S., Carmichael J., Korolchuk V., Chem C.W., Saiki S., Rose C. Huntington's disease: from pathology and genetics to potential therapies. Biochem. J. 2008, 412:191-209.
3. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeats that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
4. Martinez A., Rabano A. Anatomía patológica en la enfermedad de Huntington. Rev. Patol. 2002, 35:517-527.
5. Dunnett S.B., Carter R.J., Watts C., Torres E.M., Mahal A., Mangiarini L., Bates G., Morton A.J. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp. Neurol. 1998, 154:31-40.
6. Clabough E.B., Zeitlin S.O. Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. Hum. Mol. Genet. 2006, 15:607-623.
7. Coyle J.T., Schwarcz R. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 1976, 263:244-246.
8. Mc Lin J.P., Thompson L.M., Stewarsd O. Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainite in inbred, outbred and hybrid mouse strains. Eur. J. Neurosci. 2006, 24:3134-3140.
9. Isacson O., Brundin P., Gage F.H., Bjorklund A. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience 1985, 16:799-817.
10. Beal M.F., Brouillet E., Jenkins B.C., Ferrante R.J., Kowall N.W., Miller J.M. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 1993, 13:4181-4192.
11. Block F., Schwarz M. Expression of GFAP in the striatum and its projection areas in response to striatal quinolinic acid lesion in rats. Neuroreport 1994, 5:2237-2240.
12. Francis L., Cruz R., Antunez I., Rosillo J.C. Behavior characterization of a model of Huntington's disease in rats, induced by quinolinic acid. Rev. Neurol. 2000, 30:1016-1021.
13. Sapp E., Kegel K.B., Aronin N., Hashikawa T., Uchiyama Y., Tohyama K., Bhide P.G., Vonsattel J.P., Difiglia M. Early, progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 2001, 60:161-172.
14. Martin B., Golden E., Keselman A., Stone M., Mattson M.P., Egan J.M. Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body. Histol. Histopathol. 2008, 23:237-250.
15. Keene C.D., Sonnen J.A., Swanson P.D., Kopyov O., Leverenz J.B., Bird T.D. Neural transplantation in Huntington's disease: long-term grafts in two patients. Brain 2007, 68:2055-2056.
16. Farrington M., Wreghitt T.G., Lever A.M., Dunnett S.B., Rosser A.E., Barker R.A. Neural transplantation in Huntington's disease: the NEST-UK donor tissue microbiological screening program and review of the literature. Cell Transplant. 2006, 15:279-294.
17. Keene C.D., Chang R.C., Leverenz J.B., Kopyov O., Perlman S., Hevner R.F. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol. 2008, 117:329-339.
18. Armstrong R.J., Watts C., Svendsen C.N., Dunnett S.B., Rosser A.E. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant. 2000, 9:55-64.
19. Thompson J.A., Istkovitz-Eldor J., Hapiro S.S., Aknitz M.A., Wiergiel J.J., Arshall V.S. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
20. Lescaudron L. Autologous adult bone marrow stem cell transplantation in an animal model of Huntington's disease: behavioural and morphological outcomes. J. Neurosci. 2003, 113:945-956.
21. Kim M., Lee S.T., Chu K., Kim S.U. Stem cell-based cell therapy for Huntington disease: a review. Neuropathology 2008, 28:1-9.
22. Bjorklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 2000, 3:537-544.
23. García R., Pavón N., Vergara P., Segovia J., Alberti E. Varying expression of neurotrophic factors in rat bone marrow stromal cells according to number of culture passages. Biotecnología Aplicada 2010, 27:281-285.
24. Yaghoobi M.M.Y., Mowla S.J. Differential gene expression pattern of neurotrophins and their receptors during neuronal differentiation of rat bone marrow stromal cells. Neurosci. Lett. 2006, 397:149-154.
25. Samadi P., Boutet A., Rymar V.V., Rawal K., Maheux J., Kvann J.C., Tomaszewski M., Beaubien F., Cloutier J.F., Levesque D., Sadikot A.F. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease. Genes Brain Behav. 2013, 12:108-124.
26. Böyum A. Separation of leukocytes from blood and bone marrow. J. Clin. Lab. Invest. 1968, 21:77-84.
27. Serrano-Sánchez T., Alberti-Amador E., Lorigados-Pedre L., Díaz-Armesto I., Blanco-Lezcano L., Vallejo-Morales A. Immunophenotype characterization of rat bone marrow cell. Biotecnología Aplicada 2005, 22.
28. Sadan O., Shemesh N., Cohen Y., Melamed E., Offen D. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. Isr. Med. Assoc. J. 2009, 11:201-204.
29. Funakoshi H., Frisen J., Barbany G., Zachrisson O., Timmussk T. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J. Cell Biol. 1993, 123:455-465.
30. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997, 389:856-860.
31. Altar C.A., DiStefano P.S. Neurotrophic trafficking by anterograde transport. Trends Neurosci. 1998, 21:433-437.
32. Heerssen H.M., Pazyra M.F., Segal R.A. Dynein motors transport activated Trks to promote survival of target-dependent neurons. Nat. Neurosci. 2004, 7:596-604.
33. Javanovic J.N., Czernik A.J., Fienberg A.A., Greengard P., Sihra T.S. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat. Neurosci. 2000, 3:323-329.
34. Yoshinori T., Shinji I., Hideto K., Miwako K., Isamu Y.T.K. Brain-derived neurotrophic factor from bone marrow-derived cells promotes post-injury repair of peripheral nerve. PLoS ONE 2012, 7:44592.